The 3 patients with tumor in the lymph nodes had a significantly lower percentage of CD3+ and CD4+ T cells compared to patients (n=10) found to have no tumor in the SLN (nSLN) (p=0.0245 and p=0.028, respectively) (Figure 1). The gene discussed is CD4; the disease is neoplasm.